Acclarent, Inc. began as a privately held, venture-backed company, and is now a subsidiary of

Johnson & Johnson Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company i ...

. It is based in Irvine, Orange County,

California California is a state in the Western United States, located along the Pacific Coast. With nearly 39.2million residents across a total area of approximately , it is the most populous U.S. state and the 3rd largest by area. It is also the m ...

. Acclarent develops technology for ENT (Ear, Nose and Throat) related illnesses.

History

Acclarent was founded in 2004. The company has over 300 employees and operates in more than 45 countries. Acclarent’s corporate headquarters are located in the

Silicon Valley Silicon Valley is a region in Northern California that serves as a global center for high technology and innovation. Located in the southern part of the San Francisco Bay Area, it corresponds roughly to the geographical areas San Mateo Cou ...

in Menlo Park, California. Since inception, Acclarent has reported more than $103.5M in funding from its venture partners, New Enterprise Associates (NEA), Versant Ventures, Delphi Ventures, Meritech Capital Partners, and Johnson & Johnson Development Corporation. Acclarent was founded by Dr. Joshua Makower who currently serves as Acclarent’s Chairman of the Board. William M. Facteau was the company's President and Chief Operating Officer from November 2004 until March 2012. The company's president is currently Jeff Hopkins. In May 2005, Acclarent received FDA approval for its Relieva Balloon Sinuplasty technology. The company’s portfolio has more than 40 FDA-approved devices including the Relieva Balloon Sinuplasty systems, comprising the Relieva Ultirra sinus balloon catheters, the Relieva Luma sinus illumination guidewires, the Relieva Vortex which provides deep intra-sinus fluid delivery and strong shear flows to empty sinus contents, and the Cyclops articulating endoscope. In January 2010,

Ethicon Inc. Ethicon, Inc. is a subsidiary of Johnson & Johnson. It was incorporated as a separate company under the Johnson & Johnson umbrella in 1949 to expand and diversify the Johnson & Johnson product line. Ethicon has manufactured surgical sutures and ...

, a

company, completed the acquisition of Acclarent. In September 2017, Acclarent received FDA clearance for the Aera balloon, the first ever device to treat chronic eustachian tube dysfunction.

References

External links

*
Official USA patient website

Official UK patient website
{{Authority control Companies based in Menlo Park, California American companies established in 2004